Sophoflavescenol

Sophoflavescenol
Product Name Sophoflavescenol
CAS No.: 216450-65-6
Catalog No.: CFN90767
Molecular Formula: C21H20O6
Molecular Weight: 368.4 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Yellow powder
Targets: Caspase | ROS | NF-kB | NO | BACE | PDE
Source: The roots of Sophora flavescens Ait.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $288/5mg
Sophoflavescenol is a mixed inhibitor of PDE5 with a K(i) value of 0.005 microM. Sophoflavescenol has antioxidant, anti-inflammatory, and apoptotic effects , these effects might contribute to the antitumor activity without severe side effects. Sophoflavescenol exerts notable anti-inflammatory activity by inhibiting nitric oxide generation and tert-butylhydroperoxide-induced ROS generation rather than inhibiting nuclear factor kappa B activation in RAW 264.7 cells.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Acta Chromatographica2016, 29(3)
  • Korean Journal of Pharmacognosy2017, 48(4):320-328
  • Chem Biol Interact.2019, 315:108910
  • J Ethnopharmacol.2019, 241:112025
  • Int J Food Sci Nutr.2019, 70(7):825-833
  • FEMS Microbiol Lett.2017, 364(11)
  • Sci Rep.2018, 8(1):12970
  • Molecules.2019, 24(24),4583
  • Appl Microbiol Biotechnol.2016, 100(9):3965-77
  • Molecules.2020, 25(3):734
  • Licoflavonol

    Catalog No: CFN96515
    CAS No: 60197-60-6
    Price: Inquiry(manager@chemfaces.com)
    Topazolin

    Catalog No: CFN96520
    CAS No: 109605-79-0
    Price: Inquiry(manager@chemfaces.com)
    Cudraflavone B

    Catalog No: CFN91905
    CAS No: 19275-49-1
    Price: Inquiry(manager@chemfaces.com)
    Noricaritin

    Catalog No: CFN98528
    CAS No: 5240-95-9
    Price: $122/20mg
    Sophoflavescenol

    Catalog No: CFN90767
    CAS No: 216450-65-6
    Price: $288/5mg
    Isoanhydroicaritin

    Catalog No: CFN93597
    CAS No: 28610-30-2
    Price: Inquiry(manager@chemfaces.com)
    Icaritin

    Catalog No: CFN98527
    CAS No: 118525-40-9
    Price: $100/20mg
    Anhydroicaritin

    Catalog No: CFN98526
    CAS No: 38226-86-7
    Price: $128/20mg
    Citrusinol

    Catalog No: CFN91888
    CAS No: 112516-43-5
    Price: Inquiry(manager@chemfaces.com)
    Broussoflavonol B

    Catalog No: CFN92774
    CAS No: 99217-70-6
    Price: Inquiry(manager@chemfaces.com)
    Arch Pharm Res. 2011 Dec;34(12):2087-99.
    Anti-tumorigenic activity of sophoflavescenol against Lewis lung carcinoma in vitro and in vivo.[Pubmed: 22210035]
    This study examined the in vitro cytotoxic activity and in vivo antitumor activity as well as intracellular apoptotic capacities of a prenylated flavonol, Sophoflavescenol from Sophora flavescens, to evaluate prospective anti-tumorigenic drugs, and antitumor potential. In addition, the in vitro antioxidant and anti-inflammatory capacities were evaluated.
    METHODS AND RESULTS:
    Despite the small effect on human breast adenocarcinoma (MCF-7), Sophoflavescenol showed cytotoxicity against human leukaemia (HL-60), Lewis lung carcinoma (LLC), and human lung adenocarcinoma epithelial (A549) cells. Interestingly, it also exerted potent in vivo antitumor activity by tumor growth inhibition in the LLC tumor model as well as apoptotic activity by caspase-3 activation in HL-60 cells. In addition, it exhibited potent antioxidant activities in 1,1-diphenyl-2-picrylhydrazyl, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt radicals and lipid peroxidation assays. Sophoflavescenol exerted notable anti-inflammatory activity by inhibiting nitric oxide generation and tert-butylhydroperoxide-induced ROS generation rather than inhibiting nuclear factor kappa B activation in RAW 264.7 cells.
    CONCLUSIONS:
    The findings show that the antioxidant, anti-inflammatory, and apoptotic activities of Sophoflavescenol might contribute to the antitumor activity without severe side effects, highlighting its potential for chemoprevention and/or anticancer drugs due to multi-effective targets in almost all stages of tumorigenesis, including initiation, promotion, and progression.
    Bioorg Med Chem Lett. 2002 Sep 2;12(17):2313-6.
    A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.[Pubmed: 12161123 ]
    During the search for naturally occurring cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) inhibitors, it was found that the extracts from Sophora flavescens exhibit potent inhibitory activity against cGMP PDE5 prepared from rat diaphragm.
    METHODS AND RESULTS:
    Therefore, the inhibitory activities of five flavonoids, kushenol H (1), kushenol K (2), kurarinol (3), Sophoflavescenol (4) and kuraridine (5), isolated from S. flavescens were measured against cGMP PDE5 to identify potent cGMP PDE5 inhibitory constituents. Among tested compounds, Sophoflavescenol (4), a C-8 prenylated flavonol, showed the most potent inhibitory activity (IC(50)=0.013 microM) against cGMP PDE5 with 31.5- and 196.2-fold selectivity over PDE3 and PDE4, respectively.
    CONCLUSIONS:
    Kinetic analysis revealed that Sophoflavescenol was a mixed inhibitor of PDE5 with a K(i) value of 0.005 microM.
    Phytother Res. 2011 May;25(5):709-15.
    Antidiabetic complications and anti-Alzheimer activities of sophoflavescenol, a prenylated flavonol from Sophora flavescens, and its structure-activity relationship.[Pubmed: 21077260]
    It was previously reported that prenylated flavonols from Sophora flavescens are inhibitors of rat lens aldose reductase (RLAR), human recombinant aldose reductase (HRAR), advanced glycation endproducts (AGE), β-secretase (BACE1) and cholinesterases (ChE).
    METHODS AND RESULTS:
    Based upon structure-activity relationships, 3,4'-dihydroxy flavonols with a prenyl or lavandulyl group substitution at the C-8 position, and a hydroxy group at the C-5, are important for such inhibition. In our ongoing study to isolate active principles from S. flavescens by an activity-guided isolation procedure, further detailed phytochemical investigations of the CH(2)Cl(2) fraction were conducted via repeated chromatography over silica gel and Sephadex LH-20 columns. This ultimately resulted in the isolation of a promising active Sophoflavescenol with higher inhibitory activities among the current prenylated flavonols isolated from S. flavescens against RLAR, HRAR, AGE, BACE1 and ChEs.
    CONCLUSIONS:
    The results further support that 3,4'-dihydroxy flavonols with a prenyl or lavandulyl substitution at the C-8 position and a methoxy group at C-5 represent a new class of RLAR, HRAR and AGE inhibitors. Nevertheless, the C-5 hydroxyl group of prenylated flavonoids is important for inhibition of BACE1 and ChEs, indicating that the hydroxyl group at C-5 might be the main contributor to the augmentation and/or modification of prenylated flavonol activity.
    Arjunolic acid

    Catalog No: CFN98690
    CAS No: 465-00-9
    Price: $338/5mg
    Morusin

    Catalog No: CFN97083
    CAS No: 62596-29-6
    Price: $128/20mg
    Trifolirhizin

    Catalog No: CFN97160
    CAS No: 6807-83-6
    Price: $128/20mg
    (E)-Aldosecologanin

    Catalog No: CFN97737
    CAS No: 471271-55-3
    Price: $333/5mg
    Vicenin -3

    Catalog No: CFN92032
    CAS No: 59914-91-9
    Price: $198/20mg
    Phillygenin

    Catalog No: CFN90511
    CAS No: 487-39-8
    Price: $118/20mg
    3''-O-Galloylmyricitrin

    Catalog No: CFN95057
    CAS No: 143202-36-2
    Price: $333/5mg
    7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one

    Catalog No: CFN95140
    CAS No: 100667-52-5
    Price: $318/5mg
    Biatractylolide

    Catalog No: CFN95205
    CAS No: 182426-37-5
    Price: $268/10mg
    (1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one

    Catalog No: CFN95219
    CAS No: 1393342-06-7
    Price: $413/5mg